FDA Adverse Event Injury Summary report: N

VOLBELLA WITH LIDOCAINE

MDR report key: 8704250 · Received June 17, 2019

Report

Report Number
3005113652-2019-00467
Event Type
Injury
Date Received
June 17, 2019
Date of Event
February 15, 2019
Report Date
August 19, 2019
Manufacturer
ALLERGAN (PRINGY)
Product Code
LMH
PMA / PMN Number
P110033
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SP
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

ADDITIONAL, CHANGED, AND/OR CORRECTED DATA: DATE OF EVENT.

Description of Event or Problem · 0

HEALTHCARE PROFESSIONAL REPORTED SYMPTOMS HAVE RESOLVED.

Additional Manufacturer Narrative · 1

FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT, PRODUCT, OR PATIENT DETAILS HAS BEEN REQUESTED. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. THE EVENT OF "INFLAMMATION" IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT. A REVIEW OF THE DEVICE HISTORY RECORD HAS BEEN INITIATED. IF ANY NEW, CHANGED OR CORRECTED INFORMATION IS NOTED, A SUPPLEMENTAL MEDWATCH WILL BE SUBMITTED. THIS IS A KNOWN ADVERSE EVENT ADDRESSED IN THE PRODUCT LABELING.

Description of Event or Problem · 1

HEALTHCARE PROFESSIONAL REPORTED PATIENT WAS INJECTED WITH 1.6ML OF JUVÉDERM® VOLBELLA¿ WITH LIDOCAINE IN THE TEAR TROUGH. 8 MONTHS POST INJECTION, PATIENT PRESENTED "INFLAMMATION, NO PAIN, IN THE INJECTED SITES". TREATMENT: PREDNISONA. PATIENT "WAS BETTER" BUT ONE MONTH LATER THE INFLAMMATION APPEARED ONCE AGAIN. TREATMENT: HIALURONIDASA. SYMPTOMS ONGOING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
498752 VOLBELLA WITH LIDOCAINE IMPLANT, DERMAL, FOR AESTHETIC USE LMH ALLERGAN (PRINGY) V15LA70163

Patients

Seq Age Sex Outcome Treatment
1 37 YR Required Intervention CORTICOIDE/ARNIK| CORTICOIDE/ARNIK